|Social contacts and mixing patterns relevant to the spread of infectious diseases|
J Mossong, N Hens, M Jit, P Beutels, K Auranen, R Mikolajczyk, ...
PLoS Med 5 (3), e74, 2008
|The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study|
K Prem, Y Liu, TW Russell, AJ Kucharski, RM Eggo, N Davies, S Flasche, ...
The Lancet Public Health, 2020
|Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis|
T Malagón, M Drolet, MC Boily, EL Franco, M Jit, J Brisson, M Brisson
The Lancet infectious diseases 12 (10), 781-789, 2012
|Economic evaluation of human papillomavirus vaccination in the United Kingdom|
M Jit, YH Choi, WJ Edmunds
Bmj 337, 2008
|Age-dependent effects in the transmission and control of COVID-19 epidemics|
NG Davies, P Klepac, Y Liu, K Prem, M Jit, RM Eggo
Nature Medicine 26, 1205–1211, 2020
|Projecting social contact matrices in 152 countries using contact surveys and demographic data.|
K Prem, AR Cook, M Jit
PLoS computational biology 13 (9), e1005697, 2017
|Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation|
M Baguelin, AJ Van Hoek, M Jit, S Flasche, PJ White, WJ Edmunds
Vaccine 28 (12), 2370-2384, 2010
|Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study|
M Jit, M Brisson, A Portnoy, R Hutubessy
The Lancet Global Health 2 (7), e406-e414, 2014
|The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy|
D Cromer, AJ van Hoek, M Jit, WJ Edmunds, D Fleming, E Miller
Journal of Infection 68 (4), 363-371, 2014
|Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic …|
M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ...
The Lancet Public Health 1 (1), e8-e17, 2016
|Estimation of the impact of genital warts on health-related quality of life|
S Woodhall, T Ramsey, C Cai, S Crouch, M Jit, Y Birks, WJ Edmunds, ...
Sexually transmitted infections 84 (3), 161-166, 2008
|The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study|
S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle, ...
PLoS medicine 13 (11), e1002181, 2016
|Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England|
D Mesher, K Soldan, R Howell-Jones, K Panwar, P Manyenga, M Jit, ...
Vaccine 32 (1), 26-32, 2013
|Evaluating rotavirus vaccination in England and Wales:: Part II. The potential cost-effectiveness of vaccination|
M Jit, WJ Edmunds
Vaccine 25 (20), 3971-3979, 2007
|Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide|
J Bilcke, P Beutels, M Brisson, M Jit
Medical Decision Making 31 (4), 675-692, 2011
|Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study|
A Clark, M Jit, C Warren-Gash, B Guthrie, HHX Wang, SW Mercer, ...
The Lancet Global Health 8 (8), e1003-e1017, 2020
|Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model|
M Jit, R Chapman, O Hughes, YH Choi
BMJ 343, d5775, 2011
|Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models|
MA Penny, R Verity, CA Bever, C Sauboin, K Galactionova, S Flasche, ...
The Lancet 387 (10016), 367-375, 2016
|Modelling the transmission of healthcare associated infections: a systematic review|
E van Kleef, JV Robotham, M Jit, SR Deeny, WJ Edmunds
BMC Infectious Diseases 13 (1), 294, 2013
|Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom|
YH Choi, M Jit, N Gay, A Cox, GP Garnett, WJ Edmunds
Vaccine 28 (24), 4091-4102, 2010